Sunshine Biopharma Inc. Deferred Tax Assets, Operating Loss Carryforwards
Sunshine Biopharma Inc. (SBFM) had Deferred Tax Assets, Operating Loss Carryforwards of $7.79 million as of 2025-12-31, per its 10-K filed 2026-04-03.
Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-04-03
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $7.79M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $6.46M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $5.28M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $4.32M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $7.79M 10-K · filed 2026-04-03 | |
| 2024-12-31 | $6.46M 10-K · filed 2026-04-03 | |
| 2023-12-31 | $5.28M 10-K · filed 2025-04-01 | |
| 2022-12-31 | $4.32M 10-K · filed 2023-04-04 | |
| 2021-12-31 | $28.04M 10-K · filed 2022-03-21 | |
| 2020-12-31 | $15.94M 10-K · filed 2022-03-21 | $690.35K 10-K · filed 2021-03-30 |
| 2019-12-31 | $239.04K 10-K · filed 2021-03-30 | $349.90K 10-K · filed 2020-05-01 |
| 2018-12-31 | $388.10K 10-K · filed 2020-05-01 | $3.08M 10-K · filed 2019-04-12 |
| 2017-12-31 | $4.00M 10-K · filed 2019-04-12 | $3.95M 10-K · filed 2018-04-02 |
| 2016-12-31 | $3.61M 10-K · filed 2018-04-02 | |
| 2016-06-30 | $3.77M 10-Q · filed 2016-08-16 | |
| 2016-03-31 | $3.63M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $4.42M 10-Q · filed 2016-11-14 | $3.51M 10-Q · filed 2016-05-09 |
| 2015-09-30 | $2.87M 10-Q · filed 2015-11-04 | |
| 2014-12-31 | $3.26M 10-Q · filed 2015-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |